معرفی
Sara Tehrani is a clinical researcher at Karolinska Institutet's Department of Clinical Sciences, Danderyd Hospital, specializing in microvascular dysfunction across acute and chronic conditions. As an Affiliated Researcher and Associate Consultant in Internal Medicine, she leads investigations into sepsis, diabetes, and cardiovascular disease with focus on developing innovative bedside assessment methods for microcirculation.
Her primary research interests center on microvascular regulation and dysfunction, particularly in sepsis and diabetes. She investigates how impaired small vessel function contributes to disease progression and develops point-of-care devices for bedside microcirculation assessment. Her work spans three major clinical studies: MIND (Microangiopathy in Diabetes with 300 patients and 100 controls), SCAPIS spectrum (900 subjects with cardiovascular risk), and CapriS (60 sepsis patients and 30 controls).
Analysis of her recent publications reveals a strong focus on microvascular assessment techniques, sepsis-related cardiac dysfunction, and vascular complications of tobacco products. Her research increasingly integrates cardiovascular biomarkers with microcirculatory measurements to improve risk prediction in critical illness.
Dr. Tehrani actively supervises doctoral candidates and teaches medical students at Karolinska Institutet. Her current research is supported by multiple grants from Region Stockholm and the Swedish Society of Medicine through 2026, focusing on developing innovative methods for assessing microvascular function in clinical practice.
She leads the Clinical Research Laboratory at Danderyd Hospital and serves as Head of Research, Education & Development for the Department of Medical Specialties. Her team includes PhD students and researchers working collaboratively on microcirculation assessment and vascular dysfunction across various clinical conditions.
